All
EMA and European Chemicals Agency Strengthen Collaboration
EMA and ECHA sign agreement to share information and work together on risk assessments.
Hilary Clinton to Deliver Keynote at BIO International Convention
Hillary Clinton will deliver a keynote address at the 2014 BIO International Convention in San Diego.
Novasep Commissions Plant Extension for Highly Potent APIs
New manufacturing capacity at the Le Mans, France facility is being used to scale up antibody drug conjugates.
Merck Sells Ophthalmology Business in Japan to Santen Pharmaceutical
Santen will purchase Merck's ophthalmology products business in Japan and key markets in Europe and Asia Pacific.
AstraZeneca and MRC Laboratory of Molecular Biology Launch Joint Research Fund
AstraZeneca will collaborate with the Medical Research Council Laboratory of Molecular Biology to fund a range of pre-clinical research projects.
FDA Releases Draft Guidance on Biosimilarity
Draft guidance addresses the use of clinical pharmacology studies to determine biosimilarity of biologics.
FDA Releases Q&A on ANDAs and Stability Testing
FDA clarifies stability data recommendations for abbreviated new drug applications.
System Improves Vial Drying and Handling
Garvey's vial-drying system and pressure-less accumulator reduces drying time and decreases the risk of vial damage.
Eurofins to Acquire ViraCor-IBT Laboratories
Eurofins Scientific will acquire ViraCor-IBT Laboratories for $255 million.
KBI Biopharma Acquires Merck's Biologics Operations
KBI Biopharma acquires Merck's microbial process development and manufacturing operations in Colorado.
Shire Acquires Lumena Pharmaceuticals
Shire expands rare disease portfolio with acquisition of Lumena Pharmaceuticals.
FDA Approves Omega-3 Therapy for High Triglycerides
AstraZeneca's Epanova is the first FDA-approved prescription omega-3 in free fatty acid form.
National Institutes of Health Sets New Goals for Global Health Research and Training
The Fogarty International Center, a component of the US NIH, calls for a focus on noncommunicable diseases and implementing science in low-resource settings.
New York Genome Center and Sohn Conference Foundation Collaborate on Pediatric Cancer Research
A multi-institutional effort will fight pediatric leukemia and neuroblastoma.
FDA Revises Guidance on HABP and VABP Drugs
FDA releases draft guidance on the development of drugs to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia.
BIO and ViS Research Help Streamline Pediatric Clinical Trials
The Pediatric Clinical Research Group initiative expands to include pediatric research sites.
Bayer to Increase Position in Consumer Care Business
Bayer will acquire the consumer care business of Merck & Co., and enter a co-commercialization agreement in the field of sGC modulators.
New Translational Imaging Center Opens
MPI Research, inviCRO, and 3D Imaging open its new Translational Imaging Center in Michigan.
Ash Stevens Receives 2014 Lilly Global Supplier Award
Ash Stevens receives the 2014 Lilly Global Supplier Award.
Pharmatek Launches New API Manufacturing Program
Pharmatek develops two new cGMP manufacturing suites for API-in-capsule productions.
Janssen Pharmaceutical Collaborates with Stiching International Dispensary Association
Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.
Linking Drug Shortages and Quality Metrics
Industry players offer suggestions for quality metrics as FDA continues to try and solve the problem of drug shortages.
AstraZeneca Board Rejects Latest Pfizer Offer
AstraZeneca rejects $106 billion offer; Pfizer states its case for the merger with British government.
Antibiotic Resistance is Worldwide Threat to Public Health
WHO report provides a comprehensive picture of antibiotic resistance and suggests strategies to fight resistance.
Bristol-Myers Squibb Named First on 2014 Best Corporate Citizens List
Bristol-Myers Squibb is named No. 1 on 2014 Best Corporate Citizens List for the third time in six years.
Azzur Group and BioSPEQ Announce Merger
The Azzur Group and BioSPEQ merger will increase consulting services and project resources within the life-sciences industry.
Eli Lilly Launches Second Education Program for Medical Students
Eli Lilly has developed the Lilly Medical Student Intern Program for future physicians.
Biopharma Takes a Nervous Glance Over Its Shoulder
Changes are needed to maintain US biopharma innovation leadership.
Novartis Publishes eBook of Meningococcal Disease Survivors
Novartis' eBook features images of meningococcal disease survivors from around the world.
Shire Acquires Fibrotech
Shire acquires Fibrotech for $75 million.
